Searched for
V R RAGHAVAN
Bofors is example of case sabotaged by party with lot to hide: former CBI chief RaghavanIn his autobiography, Raghavan, who investigated the case as director of the CBI, writes scathingly about the role of the Congress but also...- Over 30 Indian vaccines in works for corona vaccine development, PM Modi toldThe PM was told on Monday that Indian vaccine companies have come across as innovators in early stage vaccine development research and thes...
- Niti Aayog, stakeholders discuss R&D requirement for coronavirus vaccineThe deadly virus, which originated in China in December last year, has spread to 155 countries, infected more than 180,000 people and claim...
- Sell Equitas Holdings, target Rs 150: Manas JaiswalSell Equitas Holdings Ltd. at a price target of Rs 150 and a stoploss at Rs 165 from entry point.
- Buy Equitas Holdings, target Rs 159: Dr CK NarayanBuy Equitas Holdings Ltd. at a price target of Rs 159.0 and a stop loss at Rs 145 from the entry point.
- Buy Equitas Holdings, target Rs 160: Manas JaiswalBuy Equitas Holdings Ltd. at a price target of Rs 160.0 and a stop loss at Rs 149 from the entry point.
- Buy Equitas Holdings, target Rs 175: Kunal BothraBuy Equitas Holdings Ltd. at a price target of Rs 175.0 and a stop loss at Rs 157 from entry point.
- Buy Equitas Holdings, target Rs 167: Manas JaiswalBuy Equitas Holdings Ltd. at a price target of Rs 167.0 and a stop loss at Rs 152 from entry point.
- Buy Equitas Holdings, target Rs 160: Shrikant ChouhanBuy Equitas Holdings Ltd. at a price target of Rs 160.0 and a stop loss at Rs 144 from entry point.
- Buy Equitas Holdings, target Rs 155: Manas JaiswalBuy Equitas Holdings Ltd. at a price target of Rs 155.0 and a stop loss at Rs 143 from entry point.
- Buy Equitas Holdings Ltd. target Rs 156.0 : Manas JaiswalBuy Equitas Holdings Ltd. at a price target of Rs 156.0 and a stoploss at Rs 147 from entry point.
- Buy Suven Life Sciences, target Rs 250: Jay ThakkarBuy Suven Life Sciences at a price target of Rs 250 and a stop loss at Rs 202 from entry point.
- Buy Suven Life Sciences, target Rs 205 : Rajesh Palviya, Axis SecuritiesBuy Suven Life Sciences at a price target of Rs 205 and a stop loss at Rs 166 from entry point.
- BJP defends Speaker Sumitra Mahajan's decision to suspend Congress MPsBJP today defended the Speaker's decision to suspend 25 Congress members for "willfully obstructing" the House, saying she was "constrained...
- Moon Mission: Giant leap for startupIt's literally a moonshot, said Sharad Sharma. Team Indus, he said, is the embodiment of the new type of Indian entrepreneur - the missiona...
- Canadian and Indian experts to dicuss clean coal technology in DelhiExperts in clean coal technology from Canada and India will converge in the capital on December 4 to mull strategies for reducing carbon em...
- IIT-Madras announces Distinguished Alumnus AwardsCorporate head honchos V Sumantran and Prabhakar Raghavan are among the winners of this year's IIT-Madras Distinguished Alumnus Award (DAA)...
- Panel to review security practicesThe government has set up a task force to review the existing practices in the national security system and suggest measures to strengthen ...
- NMS to invest Rs 9 crore to set up B-school in ChennaiThe business school which is being promoted by academicians from the US will offer diploma to students in collaboration with the Georgia Un...
- National Management school takes offThe National Management School (NMS) is one such attempt. Promoted and run by academecians from the US, it seeks to provide an intellectual...
Load More
